What is the most common causative organism of acute mastitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Causative Organism of Acute Mastitis

Staphylococcus aureus is the most common causative organism of acute mastitis in breastfeeding women. 1, 2, 3

Microbiology of Acute Mastitis

Primary Pathogen

  • Staphylococcus aureus is identified as the predominant etiological agent in acute mastitis, accounting for the majority of infective cases in lactating women 1, 2, 3
  • Recent genomic studies confirm S. aureus as the primary bacterium responsible for transitioning from a harmless component of human milk microbiota to a pathogenic agent causing mastitis 2

Other Causative Organisms

  • Staphylococcus epidermidis has been identified as another staphylococcal species associated with mastitis, though less common than S. aureus 3
  • Corynebacteria species are predominantly associated with granulomatous mastitis rather than acute mastitis 3
  • The prevalence of mastitis in breastfeeding women may reach 33%, with S. aureus being the most frequently isolated pathogen 4

Clinical Implications for Treatment

Antibiotic Selection Based on Microbiology

  • First-line antibiotics should target Staphylococcus aureus, with dicloxacillin or cloxacillin (flucloxacillin) recommended as initial therapy 1
  • For penicillin-allergic patients, cephalexin 500 mg orally every 6 hours is suggested (if no severe penicillin allergy) 1
  • The minimal transfer of dicloxacillin/cloxacillin to breast milk allows for safe continued breastfeeding during treatment 1

Antibiotic Resistance Considerations

  • The increased incidence of antibiotic resistance in S. aureus strains is a key concern for treatment, necessitating consideration of methicillin-resistant S. aureus (MRSA) in severe or refractory cases 3
  • For suspected or confirmed MRSA in severe cases requiring hospitalization, vancomycin with appropriate therapeutic monitoring is recommended 5
  • Genomic analysis reveals that S. aureus strains from mastitis cases possess complete bacteriophage genomes and specific virulence genes (such as fnbB and cna) that are absent in strains from healthy women 2

Pathogenic Mechanisms

Biofilm Formation

  • Both mastitis-associated and non-pathogenic S. aureus strains exhibit biofilm formation capacity, but mastitis-associated strains demonstrate significantly higher biofilm production 2
  • Biofilm formation within mammary ducts complicates eradication and contributes to treatment challenges 2, 3

Virulence Factors

  • Mastitis-associated S. aureus strains show stronger siderophore production, indicating a link between this trait and virulence 2
  • The presence of specific virulence genes, antibiotic resistance profiles, and bacteriophages distinguishes pathogenic S. aureus strains from commensal strains in healthy women 2

Important Clinical Caveats

  • While S. aureus is the most common organism, approximately 10% of mastitis cases progress to breast abscess formation requiring drainage 1, 5, 6
  • Culture-independent metagenomic studies reveal a loss of bacterial diversity in mastitic milk compared to healthy milk, though S. aureus remains the predominant pathogen 3
  • Effective milk removal through continued breastfeeding is essential for resolution and serves as an adjunct to antibiotic therapy 1, 5

References

Guideline

Management of Mastitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The microbiology and treatment of human mastitis.

Medical microbiology and immunology, 2018

Research

Antibiotics for mastitis in breastfeeding women.

The Cochrane database of systematic reviews, 2013

Guideline

Treatment of Mastitis in the Inpatient Setting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Mastitis During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the treatment for mastitis, especially when caused by a bacterial infection?
What is the management plan for a breastfeeding female with mastitis, presenting with breast pain, redness, and tenderness, but no fever or palpable masses?
What is the recommended first‑line oral antibiotic regimen for acute puerperal mastitis in a lactating woman, including alternatives for penicillin allergy or MRSA risk, breastfeeding advice, criteria for IV therapy, and treatment duration?
What is the recommended first-line antibiotic for acute mastitis in a breastfeeding woman?
What is the most appropriate next step for a 27-year-old postpartum (after childbirth) patient, three weeks after vaginal delivery, presenting with tenderness in her lower left breast, who is breastfeeding every two hours, with a 4 cm focal tenderness at 6 o'clock and normal vitals?
What is the recommended management for laryngitis?
What are the benefits of using gabapentin on an as‑needed (PRN) basis for intermittent neuropathic pain, breakthrough pain, muscle‑spasm discomfort, short‑term anxiety, or restless‑leg symptoms?
In a healthy 45-year-old with a positive Group C streptococcal throat culture and only a mild scratchy throat, should antibiotics be prescribed?
What is the best treatment option for a patient with major depressive disorder, recurrent moderate (F33.1), generalized anxiety disorder (F41.1), borderline personality disorder (F60.3), and autistic disorder (F84.0) who experienced uterine bleeding on sertraline and a hand rash on citalopram?
When does osteopenia become a clinical problem that warrants treatment?
What is the appropriate empiric antibiotic therapy for a 78-year-old man presenting with urinary tract infection symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.